Kinoshita, Shiori
Komatsu, Hirokazu
Fujinami, Haruna
Yoshida, Takashi
Suzuki, Tomotaka
Narita, Tomoko
Ito, Asahi
Ri, Masaki
Kusumoto, Shigeru
Iida, Shinsuke
Article History
Received: 8 March 2022
Revised: 6 September 2022
Accepted: 6 September 2022
First Online: 23 September 2022
Declarations
:
: All except two of the authors report that they have no conflict of interest to disclose. Shigeru Kusumoto has received honoraria and research funding from Chugai Pharmaceutical Co., Ltd. and Kyowa Kirin Co., Ltd. Tomotaka Suzuki has received honoraria from Chugai Pharmaceutical Co., Ltd.